Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Aiming to Become Agile, Nimble Innovative Drug Firm: Mr Kannan of Allergan
July 22, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 22, 2002
- Press Seminar
July 15, 2002
- Healthcare Reform to Raise People's Burden by \1.5 Trillion: Korosho
July 15, 2002
- Takeda, J&J to Promote Tylenol for Use on Empty Stomach
July 15, 2002
- Outline for Intellectual Property Strategy Finalized
July 15, 2002
- Asahi Beer Pham Merges Its Drug and Food Subsidiaries
July 15, 2002
- REGULATORY NEWS IN BRIEF
July 15, 2002
- OTC NEWS IN BRIEF
July 15, 2002
- National Nagano Hospital to Encourage Use of Generics
July 15, 2002
- RDKK Aims at Sales of \60 Bil., 15% Share in 2006
July 15, 2002
- Monkasho Not Intending to Abolish Department of Pharmacy
July 15, 2002
- Takara Bio Reshuffles Its Business Structure
July 15, 2002
- GLs for Epidemiological Studies Enforced
July 15, 2002
- Dainippon to Boost Overseas Sales to 7% in FY2006: President Miyatake
July 15, 2002
- DIAGNOSTIC NEWS IN BRIEF
July 15, 2002
- Takeda Expects SCOPE Results to Boost Sales of Candesartan
July 15, 2002
- MEDICAL DEVICE NEWS IN BRIEF
July 15, 2002
- Tsumura Studying Combination of Western, Oriental Medicine
July 15, 2002
- PhRMA Adopts Principles for Conduct of Clinical Trials
July 15, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…